Skip to main content

Table 1 Pharmacogenomic BMs in drug labeling

From: Are innovation and new technologies in precision medicine paving a new era in patients centric care?

Drug

Therapeutic area

Biomarker

Labeling sections

Abacavir

Infectious Diseases

HLA-B

Boxed warning, dosage and administration, contraindications, warnings and precautions

Abemaciclib (1)

Oncology

ESR

(Hormone receptor)

Indications and usage, adverse reactions, clinical studies

Abemaciclib (2)

Oncology

ERBB2

(HER2)

Indications and usage, adverse reactions, clinical studies

Ado-Trastuzumab Emtansine

Oncology

ERBB2

(HER2)

Indications and usage, warnings and precautions, adverse reactions, clinical pharmacology, clinical studies

Afatinib

Oncology

EGFR

Indications and usage, dosage and administration, adverse reactions, clinical studies

Alectinib

Oncology

ALK

Indications and usage, dosage and administration, adverse reactions, clinical pharmacology, clinical studies

Amitriptyline

Psychiatry

CYP2D6

Precautions

Anastrozole

Oncology

ESR, PGR

(Hormone receptor)

Indications and usage, adverse reactions, drug interactions, clinical studies

Arformoterol (1)

Pulmonary

UGT1A1

Clinical pharmacology

Arformoterol (2)

Pulmonary

CYP2D6

Clinical pharmacology

Aripiprazole

Psychiatry

CYP2D6

Dosage and administration, use in specific populations, clinical pharmacology

Aripiprazole lauroxil

Psychiatry

CYP2D6

Dosage and administration, use in specific populations, clinical pharmacology

Arsenic trioxide

Oncology

PML-RARA

Indications and usage

Atezolizumab

Oncology

CD274

(PD-L1)

Indications and usage, adverse reactions, clinical pharmacology, clinical studies

Atomoxetine

Psychiatry

CYP2D6

Dosage and administration, warnings and precautions, adverse reactions, drug interactions, clinical pharmacology

Ascorbic acid, PEG-3350, potassium chloride, sodium ascorbate, sodium chloride, and sodium sulfate

Gastroenterology

G6PD

Warnings and precautions

Avatrombopag (1)

Hematology

F2

(Prothrombin)

Warnings and precautions

Avatrombopag (2)

Hematology

F5

(Factor V Leiden)

Warnings and precautions

Avatrombopag (3)

Hematology

PROC

Warnings and precautions

Avatrombopag (4)

Hematology

PROS1

Warnings and precautions

Avatrombopag (5)

Hematology

SERPINC1

(Antithrombin III)

Warnings and precautions

Avelumab

Oncology

CD274

(PD-L1)

Clinical studies

Azathioprine

Rheumatology

TPMT

Dosage and administration, warnings, precautions, drug interactions, adverse reactions, clinical pharmacology

Belinostat

Oncology

UGT1A1

Dosage and administration, clinical pharmacology

Binimetinib (1)

Oncology

BRAF

Indications and usage, dosage and administration, warnings and precautions, adverse reactions, use in specific populations, clinical studies

Binimetinib (2)

Oncology

UGT1A1

Clinical pharmacology

Blinatumomab

Oncology

BCR-ABL1

(Philadelphia chromosome)

Indications and usage, clinical studies

Boceprevir

Infectious Diseases

IFNL3

(IL28B)

Clinical pharmacology

Bosutinib

Oncology

BCR-ABL1

(Philadelphia chromosome)

Indications and usage, adverse reactions, use in specific populations, clinical studies

Brentuximab vedotin

Oncology

ALK

Clinical studies

Brexpiprazole

Psychiatry

CYP2D6

Dosage and administration, use in specific populations, clinical pharmacology

Brigatinib

Oncology

ALK

Indications and usage, adverse reactions, clinical studies

Brivaracetam

Neurology

CYP2C19

Clinical pharmacology

Busulfan

Oncology

BCR-ABL1

(Philadelphia chromosome)

Clinical studies

Cabozantinib

Oncology

RET

Clinical studies

Capecitabine

Oncology

DPYD

Warnings and precautions, patient counseling information

Carbamazepine (1)

Neurology

HLA-B

Boxed warning, warnings, precautions

Carbamazepine (2)

Neurology

HLA-A

Warnings

Carglumic Acid

Inborn errors of metabolism

NAGS

Indications and usage, warnings and precautions, use in specific populations, clinical pharmacology, clinical studies

Cariprazine

Psychiatry

CYP2D6

Clinical pharmacology

Carisoprodol

Rheumatology

CYP2C19

Use in specific populations, clinical pharmacology

Carvedilol

Cardiology

CYP2D6

Drug interactions, clinical pharmacology

Celecoxib

Rheumatology

CYP2C9

Dosage and administration, use in specific populations, clinical pharmacology

Ceritinib

Oncology

ALK

Indications and usage, dosage and administration, adverse reactions, clinical studies

Cerliponase alfa

Inborn errors of metabolism

TPP1

Indications and usage, use in specific populations, clinical studies

Cetuximab (1)

Oncology

EGFR

Indications and usage, dosage and administration, warnings and precautions, adverse reactions, clinical studies

Cetuximab (2)

Oncology

RAS

Indications and usage, dosage and administration, warnings and precautions, adverse reactions, clinical studies

Cevimeline

Dental

CYP2D6

Precautions

Chloroquine

Infectious diseases

G6PD

Precautions

Chlorpropamide

Endocrinology

G6PD

Precautions

Cisplatin

Oncology

TPMT

Adverse reactions

Citalopram (1)

Psychiatry

CYP2C19

Dosage and administration, warnings, clinical pharmacology

Citalopram (2)

Psychiatry

CYP2D6

Clinical pharmacology

Clobazam

Neurology

CYP2C19

Dosage and administration, use in specific populations, clinical pharmacology

Clomipramine

Psychiatry

CYP2D6

Precautions

Clopidogrel

Cardiology

CYP2C19

Boxed warning, warnings and precautions, clinical pharmacology

Clozapine

Psychiatry

CYP2D6

Dosage and administration, use in specific populations, clinical pharmacology

Cobimetinib

Oncology

BRAF

Indications and usage, dosage and administration, adverse reactions, clinical studies

Codeine

Anesthesiology

CYP2D6

Boxed warning, warnings and precautions, use in specific populations, patient counseling information

Crizotinib (1)

Oncology

ALK

Indications and usage, dosage and administration, adverse reactions, use in specific populations, clinical pharmacology, clinical studies

Crizotinib (2)

Oncology

ROS1

Indications and usage, dosage and administration, adverse reactions, use in specific populations, clinical studies

Dabrafenib (1)

Oncology

BRAF

Indications and usage, dosage and administration, warnings and precautions, adverse reactions, clinical pharmacology, clinical studies, patient counseling information

Dabrafenib (2)

Oncology

G6PD

Warnings and precautions, adverse reactions, patient counseling information

Dabrafenib (3)

Oncology

RAS

Dosage and administration, warnings and precautions

Daclatasvir

Infectious diseases

IFNL3

(IL28B)

Clinical studies

Dapsone (1)

Dermatology

G6PD

Warnings and precautions, use in specific populations

Dapsone (2)

Dermatology

Nonspecific

(Congenital Methemoglobinemia)

Warnings and precautions

Dapsone (3)

Infectious Diseases

G6PD

Precautions, adverse reactions, overdosage

Darifenacin

Urology

CYP2D6

Clinical pharmacology

Dasabuvir, ombitasvir, paritaprevir, and ritonavir

Infectious Diseases

IFNL3

(IL28B)

Clinical studies

Dasatinib

Oncology

BCR-ABL1

(Philadelphia chromosome)

Indications and usage, dosage and administration, warnings and precautions, adverse reactions, clinical studies

Denileukin diftitox

Oncology

IL2RA

(CD25 antigen)

Indications and usage, warnings and precautions, clinical studies

Desipramine

Psychiatry

CYP2D6

Precautions

Desflurane

Anesthesiology

Nonspecific

(Genetic Susceptibility to Malignant Hyperthermia)

Contraindications

Desvenlafaxine

Psychiatry

CYP2D6

Clinical pharmacology

Deutetrabenazine

Neurology

CYP2D6

Dosage and administration, warnings and precautions, use in specific populations, clinical pharmacology

Dexlansoprazole

Gastroenterology

CYP2C19

Drug interactions, clinical pharmacology

Dextromethorphan and quinidine

Neurology

CYP2D6

Warnings and precautions, clinical pharmacology

Diazepam

Neurology

CYP2C19

Clinical pharmacology

Dinutuximab

Oncology

MYCN

Clinical studies

Dolutegravir

Infectious Diseases

UGT1A1

Clinical pharmacology

Doxepin (1)

Psychiatry

CYP2D6

Clinical pharmacology

Doxepin (2)

Psychiatry

CYP2C19

Clinical pharmacology

Dronabinol

Gastroenterology

CYP2C9

Use in specific populations, clinical pharmacology

Drospirenone and ethinyl estradiol

Gynecology

CYP2C19

Clinical pharmacology

Duloxetine

Psychiatry

CYP2D6

Drug interactions

Durvalumab

Oncology

CD274

(PD-L1)

Clinical pharmacology, clinical studies

Efavirenz

Infectious diseases

CYP2B6

Clinical pharmacology

Elbasvir and grazoprevir

Infectious diseases

IFNL3

(IL28B)

Clinical studies

Eliglustat

Inborn errors of metabolism

CYP2D6

Indications and usage, dosage and administration, contraindications, warnings and precautions, drug interactions, use in specific populations, clinical pharmacology, clinical studies

Elosulfase

Inborn errors of metabolism

GALNS

Indications and usage, warnings and precautions, use in specific populations, clinical pharmacology, clinical studies

Eltrombopag (1)

Hematology

F5

(Factor V Leiden)

Warnings and precautions

Eltrombopag (2)

Hematology

SERPINC1

(Antithrombin III)

Warnings and precautions

Enasidenib

Oncology

IDH2

Indications and usage, dosage and administration, clinical pharmacology, clinical studies

Encorafenib

Oncology

BRAF

Indications and usage, dosage and administration, warnings and precautions, adverse reactions, use in specific populations, clinical pharmacology, clinical studies

Enflurane

Anesthesiology

Nonspecific (genetic susceptibility to malignant hyperthermia)

Contraindications

Erlotinib

Oncology

EGFR

Indications and usage, dosage and administration, adverse reactions, clinical studies

Erythromycin and sulfisoxazole

Infectious Diseases

G6PD

Precautions

Escitalopram (1)

Psychiatry

CYP2D6

Drug interactions

Escitalopram (2)

Psychiatry

CYP2C19

Adverse reactions

Esomeprazole

Gastroenterology

CYP2C19

Drug interactions, clinical pharmacology

Eteplirsen

Neurology

DMD

Indications and usage, adverse reactions, use in specific populations, clinical studies

Everolimus (1)

Oncology

ERBB2

(HER2)

Indications and usage, dosage and administration, warnings and precautions, adverse reactions, drug interactions, use in specific populations, clinical studies

Everolimus (2)

Oncology

ESR

(hormone receptor)

Indications and usage, dosage and administration, warnings and precautions, adverse reactions, drug interactions, use in specific populations, clinical studies

Exemestane

Oncology

ESR, PGR

(hormone receptor)

Indications and usage, dosage and administration, clinical studies

Fesoterodine

Urology

CYP2D6

Drug interactions, clinical pharmacology

Flibanserin (1)

Gynecology

CYP2C9

Clinical pharmacology

Flibanserin (2)

Gynecology

CYP2C19

Adverse reactions, use in specific populations, clinical pharmacology

Flibanserin (3)

Gynecology

CYP2D6

Clinical pharmacology

Fluorouracil (1)

Dermatology

DPYD

Contraindications, warnings

Fluorouracil (2)

Oncology

DPYD

Warnings and precautions, patient counseling information

Fluoxetine

Psychiatry

CYP2D6

Precautions, clinical pharmacology

Flurbiprofen

Rheumatology

CYP2C9

Clinical pharmacology

Fluvoxamine

Psychiatry

CYP2D6

Drug interactions

Formoterol (1)

Pulmonary

CYP2D6

Clinical pharmacology

Formoterol (2)

Pulmonary

CYP2C19

Clinical pharmacology

Fulvestrant (1)

Oncology

ERBB2

(HER2)

Indications and usage, adverse reactions, clinical studies

Fulvestrant (2)

Oncology

ESR, PGR

(Hormone Receptor)

Indications and usage, adverse reactions, clinical pharmacology, clinical studies

Galantamine

Neurology

CYP2D6

Clinical pharmacology

Gefitinib (1)

Oncology

EGFR

Indications and usage, dosage and administration, clinical studies

Gefitinib (2)

Oncology

CYP2D6

Clinical pharmacology

Glimepiride

Endocrinology

G6PD

Warnings and precautions, adverse reactions

Glipizide

Endocrinology

G6PD

Precautions

Glyburide

Endocrinology

G6PD

Precautions

Hydralazine

Cardiology

Nonspecific

(NAT)

Clinical pharmacology

Ibrutinib (1)

Oncology

Chromosome 17p

Indications and usage, clinical studies

Ibrutinib (2)

Oncology

Chromosome 11q

Clinical studies

Iloperidone

Psychiatry

CYP2D6

Dosage and administration, warnings and precautions, drug interactions, clinical pharmacology

Imatinib (1)

Oncology

KIT

Indications and usage, dosage and administration, clinical studies

Imatinib (2)

Oncology

BCR-ABL1

(Philadelphia chromosome)

Indications and usage, dosage and administration, warnings and precautions, adverse reactions, use in specific populations, clinical pharmacology, clinical studies

Imatinib (3)

Oncology

PDGFRB

Indications and usage, dosage and administration, clinical studies

Imatinib (4)

Oncology

FIP1L1-PDGFRA

Indications and usage, dosage and administration, clinical studies

Imipramine

Psychiatry

CYP2D6

Precautions

Indacaterol

Pulmonary

UGT1A1

Clinical pharmacology

Inotuzumab Ozogamicin

Oncology

BCR-ABL1

(Philadelphia chromosome)

Clinical studies

Irinotecan

Oncology

UGT1A1

Dosage and administration, warnings and precautions, clinical pharmacology

Isoflurane

Anesthesiology

Nonspecific (genetic susceptibility to malignant hyperthermia)

Contraindications

Isoniazid, pyrazinamide, and rifampin

Infectious Diseases

Nonspecific

(NAT)

Clinical pharmacology

Isosorbide dinitrate

Cardiology

CYB5R

Overdosage

Isosorbide mononitrate

Cardiology

CYB5R

Overdosage

Ivacaftor

Pulmonary

CFTR

Indications and usage, adverse reactions, use in specific populations, clinical pharmacology, clinical studies

Ivacaftor and lumacaftor

Pulmonary

CFTR

Indications and usage, adverse reactions, use in specific populations, clinical studies

Ivacaftor and tezacaftor

Pulmonary

CFTR

Indications and usage, adverse reactions, use in specific populations, clinical pharmacology, clinical studies

Lacosamide

Neurology

CYP2C19

Clinical pharmacology

Lansoprazole

Gastroenterology

CYP2C19

Drug interactions, clinical pharmacology

Lapatinib (1)

Oncology

ERBB2

(HER2)

Indications and usage, dosage and administration, adverse reactions, use in specific populations, clinical studies

Lapatinib (2)

Oncology

ESR, PGR

(Hormone Receptor)

Indications and usage, dosage and administration, adverse reactions, use in specific populations, clinical studies

Lapatinib (3)

Oncology

HLA-DQA1, HLA-DRB1

Clinical pharmacology

Ledipasvir and sofosbuvir

Infectious diseases

IFNL3

(IL28B)

Clinical studies

Lenalidomide

Hematology

Chromosome 5q

Boxed warning, indications and usage, adverse reactions, use in specific populations, clinical studies

Lesinurad

Rheumatology

CYP2C9

Drug interactions, clinical pharmacology

Letrozole

Oncology

ESR, PGR

(Hormone Receptor)

Indications and usage, adverse reactions, clinical studies

Lidocaine and prilocaine (1)

Anesthesiology

Nonspecific

(congenital methemoglobinemia)

Warnings and precautions

Lidocaine and prilocaine (2)

Anesthesiology

G6PD

Warnings and precautions, clinical pharmacology

Lofexidine

Anesthesiology

CYP2D6

Use in specific populations

Mafenide

Infectious diseases

G6PD

Warnings, adverse reactions

Meclizine

Neurology

CYP2D6

Clinical pharmacology

Mercaptopurine (1)

Oncology

TPMT

Dosage and administration, warnings and precautions, adverse reactions, clinical pharmacology

Mercaptopurine (2)

Oncology

NUDT15

Dosage and administration, warnings and precautions, clinical pharmacology

Methylene blue

Hematology

G6PD

Contraindications, warnings and precautions

Metoclopramide (1)

Gastroenterology

CYB5R

Precautions, overdosage

Metoclopramide (2)

Gastroenterology

G6PD

Precautions, overdosage

Metoprolol

Cardiology

CYP2D6

Drug interactions, clinical pharmacology

Midostaurin (1)

Oncology

FLT3

Indications and usage, dosage and administration, adverse reactions, clinical studies

Midostaurin (2)

Oncology

NPM1

Clinical studies

Midostaurin (3)

Oncology

KIT

Clinical studies

Mirabegron

Urology

CYP2D6

Clinical pharmacology

Modafinil

Psychiatry

CYP2D6

Clinical pharmacology

Mycophenolic acid

Transplantation

HPRT1

Warnings and precautions

Nalidixic acid

Infectious diseases

G6PD

Precautions, adverse reactions

Nebivolol

Cardiology

CYP2D6

Dosage and administration, clinical pharmacology

Nefazodone

Psychiatry

CYP2D6

Precautions

Neratinib (1)

Oncology

ERBB2

(HER2)

Indications and usage, adverse reactions, clinical studies

Neratinib (2)

Oncology

ESR, PGR

(Hormone Receptor)

Clinical studies

Nilotinib (1)

Oncology

BCR-ABL1

(Philadelphia chromosome)

Indications and usage, dosage and administration, warnings and precautions, adverse reactions, use in specific populations, clinical studies

Nilotinib (2)

Oncology

UGT1A1

Clinical pharmacology

Niraparib

Oncology

BRCA

Clinical studies

Nitrofurantoin

Infectious Diseases

G6PD

Warnings, adverse reactions

Nivolumab (1)

Oncology

BRAF

Indications and usage, adverse reactions, clinical studies

Nivolumab (2)

Oncology

CD274

(PD-L1)

Clinical pharmacology, clinical studies

Nivolumab (3)

Oncology

Microsatellite instability, mismatch repair

Indications and usage, use in specific populations, clinical pharmacology, clinical studies

Nortriptyline

Psychiatry

CYP2D6

Precautions

Obinutuzumab

Oncology

MS4A1

(CD20 antigen)

Clinical studies

Olaparib

Oncology

BRCA

Indications and usage, dosage and administration, warnings and precautions, adverse reactions, clinical studies

Olaratumab

Oncology

PDGFRA

Clinical studies

Omacetaxine

Oncology

BCR-ABL1

(Philadelphia chromosome)

Clinical studies

Ombitasvir, paritaprevir, and ritonavir

Infectious diseases

IFNL3

(IL28B)

Clinical studies

Omeprazole

Gastroenterology

CYP2C19

Drug interactions, clinical pharmacology

Ondansetron

Gastroenterology

CYP2D6

Clinical pharmacology

Osimertinib

Oncology

EGFR

Indications and usage, dosage and administration, adverse reactions, clinical studies

Oxcarbazepine

Neurology

HLA-B

Warnings and precautions

Palbociclib (1)

Oncology

ESR

(Hormone Receptor)

Indications and usage, adverse reactions, clinical studies

Palbociclib (2)

Oncology

ERBB2

(HER2)

Indications and usage, adverse reactions, clinical studies

Palonosetron

Gastroenterology

CYP2D6

Clinical pharmacology

Panitumumab (1)

Oncology

EGFR

Adverse reactions, clinical pharmacology, clinical studies

Panitumumab (2)

Oncology

RAS

Indications and usage, dosage and administration, warnings and precautions, adverse reactions, clinical studies

Pantoprazole

Gastroenterology

CYP2C19

Clinical pharmacology

Parathyroid hormone

Inborn errors of metabolism

CASR

Indications and usage, clinical studies

Paroxetine

Psychiatry

CYP2D6

Drug interactions

Pazopanib (1)

Oncology

UGT1A1

Clinical pharmacology

Pazopanib (2)

Oncology

HLA-B

Clinical pharmacology

Peginterferon alfa-2b

Infectious Diseases

IFNL3

(IL28B)

Clinical pharmacology

Pegloticase

Rheumatology

G6PD

Boxed warning, contraindications, warnings and precautions, patient counseling information

Pembrolizumab (1)

Oncology

BRAF

Adverse reactions, clinical studies

Pembrolizumab (2)

Oncology

CD274

(PD-L1)

Indications and usage, dosage and administration, use in specific populations, clinical studies

Pembrolizumab (3)

Oncology

Microsatellite Instability, Mismatch Repair

Indications and usage,

Dosage and administration, use in specific populations, clinical studies 

Perphenazine

Psychiatry

CYP2D6

Precautions, clinical pharmacology

Pertuzumab (1)

Oncology

ERBB2

(HER2)

Indications and usage, warnings and precautions, adverse reactions, clinical pharmacology, clinical studies

Pertuzumab (2)

Oncology

ESR, PGR

(Hormone Receptor)

Clinical studies

Phenytoin (1)

Neurology

CYP2C9

Clinical pharmacology

Phenytoin (2)

Neurology

CYP2C19

Clinical pharmacology

Phenytoin (3)

Neurology

HLA-B

Warnings

Pimozide

Psychiatry

CYP2D6

Dosage and administration, precautions

Piroxicam

Rheumatology

CYP2C9

Clinical pharmacology

Ponatinib

Oncology

BCR-ABL1

(Philadelphia chromosome)

Indications and usage, warnings and precautions, adverse reactions, use in specific populations, clinical studies

Prasugrel (1)

Cardiology

CYP2C19

Use in specific populations, clinical pharmacology, clinical studies

Prasugrel (2)

Cardiology

CYP2C9

Use in specific populations, clinical pharmacology, clinical studies

Prasugrel (3)

Cardiology

CYP3A5

Use in specific populations, clinical pharmacology, clinical studies

Prasugrel (4)

Cardiology

CYP2B6

Use in specific populations, clinical pharmacology, clinical studies

Primaquine (1)

Infectious Diseases

G6PD

Contraindications, warnings, precautions, adverse reactions, overdosage

Primaquine (2) 

Infectious Diseases

CYB5R

Precautions, adverse reactions

Propafenone

Cardiology

CYP2D6

Dosage and administration, warnings and precautions, drug interactions, clinical pharmacology

Propranolol

Cardiology

CYP2D6

Clinical pharmacology

Protriptyline

Psychiatry

CYP2D6

Precautions

Quinidine

Cardiology

CYP2D6

Precautions

Quinine sulfate (1)

Infectious Diseases

G6PD

Contraindications

Quinine sulfate (2)

Infectious Diseases

CYP2D6

Drug interactions

Rabeprazole

Gastroenterology

CYP2C19

Clinical pharmacology

Raltegravir

Infectious Diseases

UGT1A1

Clinical pharmacology

Rasburicase (1)

Oncology

G6PD

Boxed warning, contraindications, warnings and precautions

Rasburicase (2)

Oncology

CYB5R

Boxed warning, contraindications, warnings and precautions

Ribociclib (1)

Oncology

ESR, PGR

(Hormone Receptor)

Indications and usage, clinical studies

Ribociclib (2)

Oncology

ERBB2

(HER2)

Indications and usage, clinical studies

Risperidone

Psychiatry

CYP2D6

Drug interactions, clinical pharmacology

Rituximab

Oncology

MS4A1

(CD20 antigen)

Indications and usage, dosage and administration, adverse reactions, use in specific populations, clinical studies

Rosuvastatin

Endocrinology

SLCO1B1

Clinical pharmacology

Rucaparib (1)

Oncology

BRCA

Indications and usage, dosage and administration, adverse reactions, use in specific populations, clinical studies

Rucaparib (2)

Oncology

CYP2D6

Clinical pharmacology

Rucaparib (3)

Oncology

CYP1A2

Clinical pharmacology

Sevoflurane

Anesthesiology

Nonspecific

(Genetic Susceptibility to Malignant Hyperthermia)

Warnings

Simeprevir

Infectious Diseases

IFNL3

(IL28B)

Clinical pharmacology, clinical studies

Sodium nitrite

Toxicology

G6PD

Warnings and precautions

Sofosbuvir

Infectious Diseases

IFNL3

(IL28B)

Clinical studies

Sofosbuvir and velpatasvir

Infectious Diseases

IFNL3

(IL28B)

Clinical studies

Sofosbuvir, velpatasvir, and voxilaprevir

Infectious Diseases

IFNL3

(IL28B)

Clinical studies

Succimer

Hematology

G6PD

Clinical pharmacology

Succinylcholine

Anesthesiology

BCHE

Warnings, precautions

Sulfamethoxazole and trimethoprim (1)

Infectious Diseases

G6PD

Precautions

Sulfamethoxazole and trimethoprim (2)

Infectious Diseases

Nonspecific

(NAT)

Precautions

Sulfasalazine (1)

Gastroenterology

G6PD

Precautions

Sulfasalazine (2)

Gastroenterology

Nonspecific

(NAT)

Clinical pharmacology

Tamoxifen (1)

Oncology

ESR, PGR

(Hormone receptor)

Indications and usage, precautions, adverse reactions, clinical studies

Tamoxifen (2)

Oncology

F5

(Factor V Leiden)

Warnings

Tamoxifen (3)

Oncology

F2

(Prothrombin)

Warnings

Telaprevir

Infectious Diseases

IFNL3

(IL28B)

Clinical pharmacology, clinical studies

Tetrabenazine

Neurology

CYP2D6

Dosage and administration, warnings and precautions, use in specific populations, clinical pharmacology

Thioguanine (1)

Oncology

TPMT

Dosage and administration, warnings, precautions, clinical pharmacology

Thioguanine (2)

Oncology

NUDT15

Dosage and administration, warnings, precautions, clinical pharmacology

Thioridazine 

Psychiatry

CYP2D6

Contraindications, warnings, precautions

Ticagrelor

Cardiology

CYP2C19

Clinical pharmacology

Tolterodine

Urology

CYP2D6

Precautions, clinical pharmacology

Tramadol

Anesthesiology

CYP2D6

Boxed warning, warnings, precautions, use in specific populations, clinical pharmacology

Trametinib (1)

Oncology

BRAF

Indications and usage, dosage and administration, adverse reactions, clinical pharmacology, clinical studies, patient counseling information

Trametinib (2)

Oncology

G6PD

Adverse reactions

Trametinib (3)

Oncology

RAS

Warnings and precautions

Trastuzumab (1)

Oncology

ERBB2

(HER2)

Indications and usage, warnings and precautions, clinical pharmacology, clinical studies

Trastuzumab (2)

Oncology

ESR, PGR

(Hormone receptor)

Clinical studies

Tretinoin

Oncology

PML-RARA

Indications and usage, warnings, clinical pharmacology

Trimipramine

Psychiatry

CYP2D6

Precautions

Umeclidinium

Pulmonary

CYP2D6

Clinical pharmacology

Ustekinumab

Dermatology and gastroenterology

IL12A, IL12B, IL23A

Warnings and precautions

Valbenazine

Neurology

CYP2D6

Dosage and administration, warnings and precautions, use in specific populations, clinical pharmacology

Valproic acid (1)

Neurology

POLG

Boxed warning, contraindications, warnings and precautions

Valproic acid (2)

Neurology

Nonspecific

(urea cycle disorders)

Contraindications, warnings and precautions

Vemurafenib (1)

Oncology

BRAF

Indications and usage, dosage and administration, warnings and precautions, adverse reactions, use in specific populations, clinical pharmacology, clinical studies, patient counseling information

Vemurafenib (2)

Oncology

RAS

Warnings and precautions, adverse reactions

Venlafaxine

Psychiatry

CYP2D6

Precautions

Venetoclax

Oncology

Chromosome 17p

Indications and usage, dosage and administration, use in specific populations, clinical studies

Voriconazole

Infectious Diseases

CYP2C19

Clinical pharmacology

Vortioxetine

Psychiatry

CYP2D6

Dosage and administration, clinical pharmacology

Warfarin (1)

Hematology

CYP2C9

Dosage and administration, drug interactions, clinical pharmacology

Warfarin (2)

Hematology

VKORC1

Dosage and administration, clinical pharmacology

Warfarin (3)

Hematology

PROS1

Warnings and precautions

Warfarin (4)

Hematology

PROC

Warnings and precautions

  1. The table lists 355 BMs as of December 2018, linked to drugs with pharmacogenomic information found in the drug labeling. The list of BMs includes but are not limited to germline or somatic gene variants (i.e. polymorphisms, mutations), functional deficiencies with a genetic etiology, altered gene expression signatures, and chromosomal abnormalities, and selected protein BMs that are used to select treatments for patients (adapted from Drugs@FDA; https://www.fda.gov/drugs/scienceresearch/ucm572698.htm)